抗Dxd鼠单克隆抗体-HRP标记
编号：YKMP18020H/YKMP18021H
货期：现货
规格：25ug/100ug/1mg
Background
Dxd (Exatecan derivative for ADC) is a potent DNA topoisomerase I inhibitor, with an IC50 of 0.31 μM, used as a conjugated drug of HER2-targeting ADC (DS-8201a). Dxd is cytotoxic to human cancer cell lines of KPL-4, NCI-N87, SK-BR-3, and MDA-MB-468 with IC50s of 1.43 nM-4.07 nM, but the control IgG-ADC (Dxd is the payload) shows no inhibition on the four cell lines (with HER2 expression). DS-8201a (Dxd is the payload) displays significant suppression on the HER2-positive KPL-4, NCI-N87, and SK-BR-3 cell lines, with IC50 values of 26.8, 25.4, and 6.7 ng/mL, respectively, but with no such inhibition on MDA-MB-468 (IC50, >10,000 ng/mL).
相关产品：
Anti- Dxd antibody, mAb
抗Dxd鼠单克隆抗体
编号：YKMP18020/YKMP18021
货期：现货
规格：100ug/1mg/25ug（可询价）
anti-DXD antibody, mAb - biotin label（2周交货期）
抗Dxd鼠单克隆抗体-生物素标记
编号：YKMP18020B/YKMP18021B
规格：25ul/100ul/1ml（可询价）
